The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia
Stopped in order to prepare a new clinical trial to evaluate with pathological change
Conditions
- Benign Prostatic Hyperplasia
Interventions
- DRUG: selective alpha 1-blockers
- DRUG: celecoxib
- DRUG: alpha-blocker and NSAID
Sponsor
Samsung Medical Center
Collaborators